{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:01:11Z","timestamp":1780426871609,"version":"3.54.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>Neutrophils, the most abundant white blood cells in circulation, are gaining recognition for their intricate roles in cancer biology, particularly in breast cancer. These cells can exhibit dual behavior, either promoting tumor progression through immunosuppressive mechanisms or combating cancer by enhancing anti-tumor immune responses. Tumor-associated neutrophils (TANs) are highly plastic, with their phenotype and function influenced by the tumor microenvironment. This duality underscores the complexity of targeting neutrophils for therapeutic purposes in breast cancer immunotherapy. Key mechanisms such as neutrophil extracellular traps (NETs) and immune modulation by TANs are central to their role in breast cancer. NETs contribute to cancer metastasis by facilitating tumor cell adhesion and immune evasion, while TANs can suppress cytotoxic T-cell activity through the release of immunosuppressive mediators like arginase-1 and reactive oxygen species (ROS). Empirical studies have demonstrated that high neutrophil-to-lymphocyte ratios and excessive NET formation are correlated with poor prognosis in breast cancer patients, particularly those with aggressive subtypes such as triple-negative breast cancer.<\/jats:p>","DOI":"10.1097\/md.0000000000044831","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:01:12Z","timestamp":1759248072000},"page":"e44831","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Neutrophils and cancer immunotherapy: Potential mechanisms and challenges in breast cancer \u2013 a narrative review"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-0161","authenticated-orcid":false,"given":"Emmanuel Ifeanyi","family":"Obeagu","sequence":"first","affiliation":[{"name":"Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"4736091","DOI":"10.1155\/2020\/4736091","article-title":"Heterogeneity of tumors in breast cancer: implications and prospects for prognosis and therapeutics.","volume":"2020","author":"Tuasha","year":"2020","journal-title":"Scientifica"},{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1007\/s11033-021-06752-9","article-title":"Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets.","volume":"48","author":"Kumar","year":"2021","journal-title":"Mol Biol Rep"},{"key":"R3-20260602","first-page":"849","article-title":"Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies.","volume":"21","author":"Zhang","year":"2024","journal-title":"Cancer Biol Med"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/JLB.4MIR0220-574RR","article-title":"Neutrophils at the crossroads of innate and adaptive immunity.","volume":"108","author":"Rosales","year":"2020","journal-title":"J Leukoc Biol"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.7150\/thno.111096","article-title":"Targeting neutrophil extracellular traps in cancer progression and metastasis.","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/febs.14206","article-title":"Neutrophils, G\u2010CSF and their contribution to breast cancer metastasis.","volume":"285","author":"Mouchemore","year":"2018","journal-title":"FEBS J"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"118699","DOI":"10.1016\/j.lfs.2020.118699","article-title":"Tumor-associated neutrophils as new players in immunosuppressive process of the tumor microenvironment in breast cancer.","volume":"264","author":"Hajizadeh","year":"2021","journal-title":"Life Sci"},{"key":"R8-20260602","doi-asserted-by":"crossref","first-page":"106996","DOI":"10.1016\/j.phrs.2023.106996","article-title":"Neutrophils as potential therapeutic targets for breast cancer.","volume":"198","author":"Gong","year":"2023","journal-title":"Pharmacol Res"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13058-023-01676-7","article-title":"Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance.","volume":"25","author":"Zheng","year":"2023","journal-title":"Breast Cancer Res"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2016.217","article-title":"TNF\u03b1-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils.","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/14728222.2021.1954162","article-title":"Tumor-associated neutrophils: orchestrating cancer pathobiology and therapeutic resistance.","volume":"25","author":"Bui","year":"2021","journal-title":"Expert Opin Ther Targets"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"e37654","DOI":"10.1097\/MD.0000000000037654","article-title":"Exploring neutrophil functionality in breast cancer progression: a review.","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"117211","DOI":"10.1016\/j.biopha.2024.117211","article-title":"How neutrophils shape the immune response of triple-negative breast cancer: Novel therapeutic strategies targeting neutrophil extracellular traps.","volume":"178","author":"Liang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"R14-20260602","first-page":"18","article-title":"Breast cancer: a molecularly heterogenous disease needing subtype-specific treatments.","volume":"8","author":"Testa","year":"2020","journal-title":"Med Sci"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"101546","DOI":"10.1016\/j.smim.2021.101546","article-title":"Impact of cancer cell-intrinsic features on neutrophil behavior.","volume":"57","author":"Duits","year":"2021","journal-title":"Semin Immunol"},{"key":"R16-20260602","first-page":"2689","article-title":"Tumor-associated neutrophils in breast cancer subtypes.","volume":"18","author":"Soto-Perez-de-Celis","year":"2017","journal-title":"Asian Pacific J Cancer Prev"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.3390\/cancers13112584","article-title":"Pivotal role for Cxcr2 in regulating tumor-associated neutrophil in breast cancer.","volume":"13","author":"Timaxian","year":"2021","journal-title":"Cancers"},{"key":"R18-20260602","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.3390\/cancers12061542","article-title":"Neutrophil extracellular traps (NETs) promote pro-metastatic phenotype in human breast cancer cells through epithelial\u2013mesenchymal transition.","volume":"12","author":"Martins-Cardoso","year":"2020","journal-title":"Cancers"},{"key":"R19-20260602","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13058-019-1237-6","article-title":"Neutrophil extracellular traps in breast cancer and beyond: current perspectives on NET stimuli, thrombosis and metastasis, and clinical utility for diagnosis and treatment.","volume":"21","author":"Snoderly","year":"2019","journal-title":"Breast Cancer Res"},{"key":"R20-20260602","doi-asserted-by":"crossref","first-page":"e36905","DOI":"10.1097\/MD.0000000000036905","article-title":"Breast cancer: a review of risk factors and diagnosis.","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"e37695","DOI":"10.1097\/MD.0000000000037695","article-title":"Exploring the profound link: Breastfeeding\u2019s impact on alleviating the burden of breast cancer \u2013 a review.","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"R22-20260602","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1097\/MS9.0000000000002517","article-title":"Predictive models and biomarkers for survival in stage III breast cancer: a review of clinical applications and future directions.","volume":"86","author":"Obeagu","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"R23-20260602","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1097\/MS9.0000000000001914","article-title":"Breastfeeding\u2019s protective role in alleviating breast cancer burden: a comprehensive review.","volume":"86","author":"Obeagu","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"R24-20260602","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.3390\/cancers14133287","article-title":"Breast cancer stem cells: signaling pathways, cellular interactions, and therapeutic implications.","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"key":"R25-20260602","doi-asserted-by":"crossref","first-page":"eadf6493","DOI":"10.1126\/science.adf6493","article-title":"Deterministic reprogramming of neutrophils within tumors.","volume":"383","author":"Ng","year":"2024","journal-title":"Science"},{"key":"R26-20260602","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.3390\/ijms24086945","article-title":"Therapeutic potential of tumor metabolic reprogramming in triple-negative breast cancer.","volume":"24","author":"Munk\u00e1csy","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R27-20260602","doi-asserted-by":"crossref","first-page":"659996","DOI":"10.3389\/fimmu.2021.659996","article-title":"Triple-negative breast cancer cells recruit neutrophils by secreting TGF-\u03b2 and CXCR2 ligands.","volume":"12","author":"SenGupta","year":"2021","journal-title":"Front Immunol"},{"key":"R28-20260602","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.7150\/jca.94669","article-title":"Neutrophil extracellular traps in breast cancer: roles in metastasis and beyond.","volume":"15","author":"Xu","year":"2024","journal-title":"J Cancer"},{"key":"R29-20260602","doi-asserted-by":"crossref","first-page":"937565","DOI":"10.3389\/fimmu.2022.937565","article-title":"Neutrophil extracellular traps: New players in cancer research.","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"R30-20260602","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biomaterials.2016.04.027","article-title":"An overview of the effective combination therapies for the treatment of breast cancer.","volume":"97","author":"N\u00fa\u00f1ez","year":"2016","journal-title":"Biomaterials"},{"key":"R31-20260602","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/jnci\/djh131","article-title":"Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.","volume":"96","author":"Pegram","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R32-20260602","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/tpj.2011.48","article-title":"A genomic approach to predict synergistic combinations for breast cancer treatment.","volume":"13","author":"Soldi","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"R33-20260602","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.","volume":"101","author":"Cheang","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R34-20260602","doi-asserted-by":"crossref","first-page":"1228076","DOI":"10.3389\/fonc.2023.1228076","article-title":"The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review.","volume":"13","author":"Heshmat-Ghahdarijani","year":"2023","journal-title":"Front Oncol"},{"key":"R35-20260602","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.fob.2015.05.003","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer.","volume":"5","author":"Chen","year":"2015","journal-title":"FEBS Open Bio"},{"key":"R36-20260602","doi-asserted-by":"crossref","first-page":"112788","DOI":"10.1016\/j.intimp.2024.112788","article-title":"Neutrophils\u2019 dual role in cancer: from tumor progression to immunotherapeutic potential.","volume":"140","author":"Wu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"R37-20260602","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.ajpath.2013.08.002","article-title":"Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine.","volume":"183","author":"Rivenbark","year":"2013","journal-title":"Am J Pathol"},{"key":"R38-20260602","doi-asserted-by":"crossref","first-page":"104683","DOI":"10.1016\/j.phrs.2020.104683","article-title":"Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer.","volume":"153","author":"Deepak","year":"2020","journal-title":"Pharmacol Res"},{"key":"R39-20260602","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3389\/fimmu.2019.02155","article-title":"Neutrophil heterogeneity in cancer: from biology to therapies.","volume":"10","author":"Lecot","year":"2019","journal-title":"Front Immunol"},{"key":"R40-20260602","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.3390\/cancers13112832","article-title":"Neutrophil extracellular traps in tumor metastasis: pathological functions and clinical applications.","volume":"13","author":"Chen","year":"2021","journal-title":"Cancers"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:02:10Z","timestamp":1780423330000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":40,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044831","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2024-12-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}